Characteristic | Studied patients (n = 127) | ||
---|---|---|---|
Normal PWV (n = 59) | Abnormal PWV (n = 68) | P | |
Age (y) | 56.4 ± 10.9 | 60.3 ± 8.7 | 0.032 |
Male sex (%) | 30.5 | 48.5 | 0.039 |
baPWV (cm/s) | 1247.2 ± 292.0 | 2218.4 ± 528.7 | <0.001 |
DM (%) | 10.2 | 35.3 | 0.001 |
Inradialytic hypotension (%) | 34.5 | 8.8 | <0.001 |
Always hypotension (%) | 8.8 | 0 | 0.013 |
HDF (%) | 18.6 | 14.7 | 0.551 |
Hb (g/dL) | 10.5 ± 1.4 | 10.5 ± 1.3 | 0.744 |
BUN (mg/dL) | 65.0 ± 15.7 | 64.5 ± 16.1 | 0.864 |
Cr (mg/dL) | 11.1 ± 2.1 | 10.6 ± 2.7 | 0.223 |
Na (mEq/L) | 139.6 ± 3.2 | 140.0 ± 3.1 | 0.518 |
K (mEq/L) | 4.8 ± 0.7 | 4.9 ± 0.6 | 0.511 |
Calcium (mg/dL) | 9.7 ± 1.0 | 9.9 ± 1.0 | 0.276 |
Phosphorous (mg/dL) | 4.6 ± 1.5 | 4.6 ± 1.4 | 0.815 |
Calcium-phosphorous product (mg/dL)2 | 46.7 ± 16.5 | 45.4 ± 16.2 | 0.667 |
Alb (g/dL) | 4.0 ± 0.2 | 4.1 ± 0.4 | 0.429 |
Total cholesterol (mg/dL) | 180.5 ± 39.1 | 189.4 ± 38.0 | 0.199 |
Triglyceride (mg/dL) | 195.5 ± 130.0 | 226.1 ± 177.5 | 0.276 |
Ultrafiltration amount per dialysis session (L) | 2.5 ± 1.2 | 2.0 ± 0.9 | 0.017 |
SBP (mmHg) | 129.2 ± 29.3 | 147.9 ± 21.5 | <0.001 |
ABI | 1.00 ± 0.15 | 1.05 ± 0.12 | 0.055 |
TBI | 0.72 ± 0.16 | 0.73 ± 0.15 | 0.545 |
Body Mass Index (kg/m2) | 22.6 ± 3.1 | 22.5 ± 3.4 | 0.916 |
iPTH (pg/mL) | 188.6 ± 201.9 | 193.7 ± 234.6 | 0.898 |
Urea reduction rate | 0.78 ± 0.06 | 0.78 ± 0.06 | 0.747 |
Kt/V | 1.8 ± 0.3 | 1.8 ± 0.4 | 0.655 |
Net protein catabolic rate (g/day/kg body weight) | 1.2 ± 0.4 | 1.2 ± 0.4 | 0.946 |
Al (ng/mL) | 8.8 ± 5.7 | 10.4 ± 8.9 | 0.232 |
Hemodialysis duration (months) | 78.7 ± 67.8 | 67.2 ± 56.0 | 0.298 |
hsCRP (mg/L) | 3.4 ± 3.5 | 5.8 ± 7.7 | 0.023 |
NO2 (ppb) | 22.9 ± 3.6 | 22.9 ± 4.0 | 0.984 |
CO (ppm) | 0.63 ± 0.17 | 0.64 ± 0.22 | 0.890 |
SO2 (ppb) | 6.7 ± 2.0 | 7.2 ± 2.1 | 0.184 |
PM10 (ug/m3) | 57.2 ± 5.4 | 58. ± 5.9 | 0.226 |
PM2.5 (ug/m3) | 31.6 ± 2.9 | 31.9 ± 2.8 | 0.513 |
O3 (ppb) | 25.7 ± 2.8 | 26.0 ± 2.9 | 0.480 |
NO (ppb) | 9.9 ± 4.7 | 10.4 ± 9.8 | 0.707 |